[Laparoscopic adrenalectomy: an initial experience].
Our aim was to evaluate the short-term results of a series of 65 consecutive laparoscopic adrenalectomies performed on 63 patients with benign or metastatic tumours measuring < or = 7 cm. The surgical indication was primary hyperaldosteronism in 32 cases, pheochromocytoma in 7, Cushing syndrome and disease in 5 and 2 cases, respectively, incidentaloma in 11 and metastasis in 8 cases. The mean tumour size was 3.9 cm (range 0.6-7). Operative time averaged 130 min (range 45-270). In one case we produced an iatrogenic lesion by sectioning a peripheral recurrent branch of the left renal artery with consequent partial renal infarction. The conversion rate to the open approach was 6.1%; the morbidity rate was 4.6%. The mean hospital stay was 4 days (range 3-11). All patients were re-examined 30 days after surgery and no additional complications were observed. At this time 93.2% of patients with primary secreting tumours showed normal hormonal assays. Considering the 38 patients chronically treated during the preoperative period, we noted that the intake of specific drugs was suspended in 34.2%, reduced in 36.8%, maintained in 26.4% and transitorily augmented in 2.6%. On these basis we confirm the efficacy and safety of this surgical treatment.
Tiberio
Guido Alberto Massimo
GA
Clinica Chirurgica - Università di Brescia - III Divisione di Chirurgia Generale Spedali Civili di Brescia - Piazzale Spedali Civili, 1 -25100 Brescia.
Piardi
Tullio
T
Cerea
Katia
K
Ronconi
Maurizio
M
Bertoloni
Giampaolo
G
Frassi
Eleonora
E
Portolani
Nazario
N
Giulini
Stefano Maria
SM
D000310:Adrenal Gland Neoplasms / Q000601:surgery*; D000315:Adrenalectomy / Q000009:adverse effects / Q000379:methods; D000328:Adult; D000368:Aged; D003480:Cushing Syndrome / Q000601:surgery; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000601:surgery; D010535:Laparoscopy / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D010673:Pheochromocytoma / Q000601:surgery; D012189:Retrospective Studies; D016896:Treatment Outcome